Study determines higher dosage of radioembolization to treat liver cancer improves survival rates

A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) has determined the benefits of using a higher dosage of radioembolization treatment using yttrium-90 (Y-90) microspheres, than previously recommended, for liver cancer. Patients who received this elevated dose had significantly better outcomes than those who did not…